[1] Everard A,Belzer C,Geurts L,et al. Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA,2013,110:9066-9071.
[2] Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology,2011,54:562-572.
[3] Qin J,Li Y,Cai Z,et al.A metafenome-wide association study of gut microbiota in type 2diabetes.Nature,2012,490:55-60.
[4] Giannelli V, Di Gregorio V, Giusto M, et al. Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis. World J Gastoenterol, 2014, 20: 16795-16810.
[5] Li K, Bihan M, Methé BA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One, 2013, 8:e63139.
[6] Wei X,Yan X,Zou D,et al. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach.BMC Gastroenterol,2013,13: 175.
[7] Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol, 2014, 60: 940-947.
[8] Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology, 2011, 54: 562-572.
[9] Norman K,Pirlich M,Schulzke JD,et al.Increased intestinal permeability in malnourished patients with liver cirrhosis. Eur J Clin Nutr,2012,66: 1116-1119.
[10] Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol, 2013, 58:949-955.
[11] Giannelli V, Di Gregorio V, Lucidi C, et al. Does the gut microbiota modulate the inflammatory state in cirrhotic host? J Hepatol, 2014, 60:S41.
[12] Stevens DA, Kim KK, Johnson N, et al. Halomonas johnsoniae: review of a medically underappreciated genus of growing human importance. Am J Med Sci, 2013, 345:335-338.
[13] Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol, 2012, 302:G168-G175.
[14] Merli M, Giusto M, Lucidi C, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis, 2013, 28:281-284.
[15] Cesaro C, Tiso A, Del Prete A, et al. Gut microbiota and probiotics in chronic liver dieases. Dig Liver Dis, 2011,43: 431-438.
[16] Bajaj JS, Hylemon PB, Ridlon JM, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol, 2012, 303:G675-G685.
[17] Garcia-Tsao G, Wiest R.Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol, 2014, 18: 353-372.
[18] Balan G, Tr ifan A, Botezatu D, et al. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. Rev Med Chir Soc Med Nat Iasi, 2011, 115: 38-44.
[19] Guamer C,Soriano G.Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol,2012,17:27-31.
[20] Lu H, Wu Z, Xu W, et al. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol, 2011, 61:693-703.
[21] Abd Elaal MM, Zaghloul SG, Bakr HG, et al. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis. Arab J Gastroenterol, 2012,13:65-70.
[22] Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the designof clinical trials in hepatic encephalopathy: an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther, 2011, 33: 739-747.
[23] Fritz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med, 2013, 187: 133-143.
[24] Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology, 2014, 59: 1627-1637.
[25] Bauer TM, Schwacha H, Steinbruckner B, et al.Small intestinal bacterial vergrowth in human cirrhosis is associatedwith systemic endotoxemia. Am J Gastroent erol, 2012, 97: 2364-2370.
[26] Lata J,Jurankova J,Kopacova M,et al. Probiotics in hepatology. World J Gastroenterol,2011,17: 2890-2896.
[27] Shukla S,Shukla A,Mehboob S,et al. Meta-analysis: the effects of gut flora modulation using prebiotics,probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther,2011,33: 662-671.
[28] Gomez-Hurtado I,Santacruz A,Peiro G,et al. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One,2011,6: 230-237.
[29] 侯天舒,韩晓霞,杨阳,等. 电针对溃疡性结肠炎大鼠肠道微生态的保护作用. 针刺研究,2014,39: 27-34.
[30] 郭晓明,徐珊,郭锦瑞,等. 温运合剂对脾虚泄泻小鼠的肠道功能及肠道菌群的保护作用研究. 现代中西医结合杂志,2014,23: 1711-1720.
[31] Cesaro C,Tiso A,Del Prete A,et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis,2011,43: 431-438. |
